Articles from Cardiovascularbusiness.com

1. St. Jude, Volcano battle in court over FFR technology

   Explore Article Cardiovascularbusiness.com (Jul 28 2010) Cardiology , Other Business News

   St. Jude Medical has filed a lawsuit against Volcano for patent infringement, including its PrimeWire pressure guidewire products, infringe on patents used for St. Jude’s PressureWire technology platform, which was acquired from Radi Medical Systems. In response, Volcano said it will “vigorously defend” itself against the lawsuit. The suit involves five St. Jude patents and seeks injunctive relief and monetary damages, according to the St. Paul, Minn.-based company. The PressureWire interventional technology measures fractional flow reserve (FFR). (Read Full Article)
   

   Comment on Article Mentions:   LightLab Imaging   Axsun Technologies   St. Jude Medical

2. Clinical relevance of DES implantation problems highlighted by OCT remains unclear

   Explore Article Cardiovascularbusiness.com (Oct 3 2008) Cardiology

   In a first study of its kind, researchers in Japan using serial optical coherence tomography (OCT) imaging found that patients with unstable and stable angina have markedly different vascular responses to drug-eluting stents, and that those with unstable angina have greater risk of certain complications. The findings, however, were not associated with adverse outcomes in patients taking dual-antiplatelet therapy. While sirolimus-eluting stents (SES) reduce the need for target-vessel revascularization, they impair local vascular healing with delayed endothelization, the authors wrote. Patients with unstable angina pectoris (UAP), compared to those with stable angina pectoris (SAP), present a greater risk for thrombotic ... (Read Full Article)
   

   Comment on Article Mentions:   Cordis   Lightlab ImageWire   Wakayama Medical University

1-2 of 2